OOIR: Observatory of International Research

Papers

(The H4-Index of ESC Heart Failure is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Corrigendum	102
	81
Right ventricular strain predicts outcome in patients receiving sacubitril/valsartan: A sub‐analysis of DISCOVER‐ARNI	80
Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices	70
Establishing a novel model to assess exercise capacity in chronic heart failure based on stress echocardiography	68
Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation	65
Systolic dysfunction and mortality in critically ill patients: more data are needed to believe in this association!	61
Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry	55
Serum angiotensin‐converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy	54
Blood perfusion status is important in the prognosis of ventricular aneurysm complicated by ventricular septal rupture	51
Editors' highlight picks from 2023 in ESC heart failure	48
Characteristics and management of very elderly patients with heart failure: a retrospective, population cohort study	47
Issue Information	45
Burden of hospitalizations in newly diagnosed heart failure patients in Poland: real world population based study in years 2013–2019	45
Cardiogenic shock requiring VA‐ECMO therapy in scorpionism‐induced myocarditis	44
Intense optimization of oral therapy rapidly restores respiratory function in worsening heart failure patients	43
Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach	42
Use of sodium glucose co‐transporter 2 inhibitors in acute heart failure: a practical guidance	42
Predictive value of global longitudinal strain by left ventricular ejection fraction	42
Global differences in acute heart failure treatment: analysis of the STRONG‐HF site feasibility questionnaire	41
Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices	41
Analysis of the serum levels of RIP3 and Drp1 in patients with heart failure	41
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study	41
Assessing the link of malnutrition with diabetes and mortality risk in heart failure patients	41
Risk classification for long‐term mortality among patients with acute heart failure: China PEACE 4YMortality	40

	39
Oral iron supplementation in patients with heart failure: a systematic review and meta‐analysis	38
Early achievement of walkability after cardiac surgery and the risk of cardiovascular disease after hospital discharge	38
Meta‐Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease	38
Explainable machine learning and online calculators to predict heart failure mortality in intensive care units	38
Synchronized diaphragmatic stimulation: a case report of a novel extra‐cardiac intervention for chronic heart failure	37
Sex differences in the impact of frailty on patients with heart failure: A retrospective cohort study	36
Cardiac involvement in patients recovering from Delta Variant of COVID‐19: a prospective multi‐parametric MRI study	36
Use of liver stiffness measurements in acute decompensated heart failure: new applications of a non‐invasive technique	36
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis	36
Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure	36